-- 加拿大皇家銀行資本市場（RBC Capital Markets）週五透過電子郵件發送的一份研究報告指出，聯合太平洋鐵路公司（UNP）第一季度展現出強勁的基本營運指標，這些指標具有可持續性，並可能與更佳的貨運量預期相輔相成，進一步推動業績指引上調。 分析師在報告中寫道，儘管併購預期將是影響股價表現的因素，但建築業被列為新的成長動力，而汽車業則因貨運環境可能改善而從負面評級轉為中性評級。 報告稱，第一季獲利超預期主要得益於貨運量和利潤率的提升，而營收與預期相符則可能歸功於核心價格上漲和燃油附加費收入增加。 該券商表示，維持對該股的「跑贏大盤」評級，並將目標股價從每股273美元上調至289美元。
Price: $272.04, Change: $+0.78, Percent Change: +0.29%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.